InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: eb0783 post# 246123

Friday, 12/18/2015 3:26:08 PM

Friday, December 18, 2015 3:26:08 PM

Post# of 346131
Nice post Eb; I would only mention that Roche


kept Genentech in South San Francisco after the buyout in 2009, and did not move it to Nutley, NJ (where Roche's U.S. base is).

They also left the scientific bench labs alone and didn't touch them, leaving them with autonomy. While some scientists did leave, many remained. Roche has continued to do well, and is, in fact, the third largest BP in the world.

I like your idea that any combination of stock/cash/percentage buyout is possible. The cell membrane is the crucial communicator with the immune system. We control the key membrane PS-signaling checkpoint for IO.

BP will come up with whatever combination they need to get their hands on it.

Regards,

Joe
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News